Rare
lephants
Screener
Toggle theme
Ironwood Pharmaceuticals, Inc.
IRWD
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Total Cash from Operations:
$273.8M
Line Item
Value
% of Total
Capital Expenditures
$136.0K
0.0%
Stock Repurchases
$126.4M
46.2%
Other Financing
$111.2M
40.6%
Net Cash Flow
$36.1M
13.2%
Download CSV
